{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T18:17:33Z","timestamp":1794766653363,"version":"4.9.1"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009634","name":"The Susan G Komen Breast Cancer Foundation Inc","doi-asserted-by":"publisher","award":["CCR19609205"],"award-info":[{"award-number":["CCR19609205"]}],"id":[{"id":"10.13039\/100009634","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007208","name":"Vanderbilt-Ingram Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007208","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["2444112"],"award-info":[{"award-number":["2444112"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1937963"],"award-info":[{"award-number":["1937963"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019549","name":"Vanderbilt Institute of Nanoscale Science and Engineering, Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.biomaterials.2026.124238","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:08:59Z","timestamp":1777561739000},"page":"124238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A molecularly defined polymeric platform for environmentally responsive activation of STING to enhance cancer immunotherapy"],"prefix":"10.1016","volume":"334","author":[{"given":"Jacob A.","family":"Schulman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-1637","authenticated-orcid":false,"given":"Karan","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4566-3564","authenticated-orcid":false,"given":"Neil C.","family":"Chada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6080-2924","authenticated-orcid":false,"given":"Julia A.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7611-6120","authenticated-orcid":false,"given":"Hayden M.","family":"Pagendarm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan E.","family":"Woodworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor L.","family":"Sheehy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1846-1580","authenticated-orcid":false,"given":"Katherine","family":"Gibson-Corley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4263-5974","authenticated-orcid":false,"given":"Justin M.","family":"Balko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9144-2634","authenticated-orcid":false,"given":"John T.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2026.124238_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.str.2024.01.008","article-title":"Fluorinated cGAMP analogs, which act as STING agonists and are not cleavable by poxins: structural basis of their function","volume":"32","author":"Klima","year":"2024","journal-title":"Structure"},{"key":"10.1016\/j.biomaterials.2026.124238_bib2","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/s41422-020-0343-4","article-title":"Immune checkpoint signaling and cancer immunotherapy","volume":"30","author":"He","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.biomaterials.2026.124238_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1200\/EDBK_240837","article-title":"Mechanisms of resistance to immune checkpoint blockade: why does checkpoint inhibitor immunotherapy not work for all patients?","author":"Fares","year":"2019","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"10.1016\/j.biomaterials.2026.124238_bib4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.immuni.2016.06.001","article-title":"Resistance mechanisms to immune-checkpoint blockade in cancer: Tumor-Intrinsic and -Extrinsic factors","volume":"44","author":"Pitt","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2026.124238_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41577-019-0218-4","article-title":"Tumour-intrinsic resistance to immune checkpoint blockade","volume":"20","author":"Kalbasi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/nrc.2017.17","article-title":"Prospects for combining targeted and conventional cancer therapy with immunotherapy","volume":"17","author":"Gotwals","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124238_bib7","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment: immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib8","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib9","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1021\/acs.chemrev.1c00750","article-title":"Chemical and biomolecular strategies for STING pathway activation in cancer immunotherapy","volume":"122","author":"Garland","year":"2022","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124238_bib10","doi-asserted-by":"crossref","unstructured":"J. Le Naour, L. Zitvogel, L. Galluzzi, E. Vacchelli, G. Kroemer, Trial watch: STING agonists in cancer therapy, Oncoimmunology 9 (n.d.) 1777624. https:\/\/doi.org\/10.1080\/2162402X.2020.1777624.","DOI":"10.1080\/2162402X.2020.1777624"},{"key":"10.1016\/j.biomaterials.2026.124238_bib11","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1158\/2326-6066.CIR-14-0099","article-title":"STING contributes to antiglioma immunity via triggering type I IFN signals in the tumor microenvironment","volume":"2","author":"Ohkuri","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biomaterials.2026.124238_bib12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41590-024-01872-3","article-title":"The balance of STING signaling orchestrates immunity in cancer","volume":"25","author":"Lanng","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib13","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.add1153","article-title":"STING-activating nanoparticles normalize the vascular-immune interface to potentiate cancer immunotherapy","volume":"8","author":"Wang-Bishop","year":"2023","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib14","first-page":"1","article-title":"Potentiating cancer immunotherapies with modular albumin-hitchhiking nanobody\u2013STING agonist conjugates","author":"Kimmel","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2026.124238_bib15","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/nchembio.1661","article-title":"Hydrolysis of 2\u20323\u2032-cGAMP by ENPP1 and design of nonhydrolyzable analogs","volume":"10","author":"Li","year":"2014","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib16","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1021\/acs.orglett.3c03908","article-title":"Synthesis of original cyclic dinucleotide analogues using the Sulfo-click reaction","volume":"26","author":"Amador","year":"2024","journal-title":"Org. Lett."},{"key":"10.1016\/j.biomaterials.2026.124238_bib17","doi-asserted-by":"crossref","first-page":"7354","DOI":"10.1021\/cr300011s","article-title":"(3\u2032-5\u2032)-Cyclic dinucleotides: synthetic strategies and biological potential","volume":"113","author":"Clivio","year":"2013","journal-title":"Chem. Rev."},{"key":"10.1016\/j.biomaterials.2026.124238_bib18","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s11912-023-01361-0","article-title":"The development of STING agonists and emerging results as a cancer immunotherapy","volume":"25","author":"Hines","year":"2023","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.biomaterials.2026.124238_bib19","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.3390\/jcm9103323","article-title":"Challenges and opportunities in the clinical development of STING agonists for cancer immunotherapy","volume":"9","author":"Motedayen Aval","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biomaterials.2026.124238_bib20","doi-asserted-by":"crossref","first-page":"84","DOI":"10.36401\/JIPO-22-8","article-title":"The contemporary landscape and future directions of intratumoral immunotherapy","volume":"6","author":"Brito-Orama","year":"2023","journal-title":"J Immunother Precis Oncol"},{"key":"10.1016\/j.biomaterials.2026.124238_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500296","article-title":"STING agonists and how to reach their full potential in cancer immunotherapy","volume":"12","author":"Gehrcken","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.biomaterials.2026.124238_bib22","doi-asserted-by":"crossref","first-page":"3400","DOI":"10.1158\/1078-0432.CCR-24-3630","article-title":"Phase I and II clinical studies of the STING agonist ulevostinag with and without pembrolizumab in participants with advanced or metastatic solid tumors or lymphomas","volume":"31","author":"Harrington","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124238_bib23","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.3390\/cancers13112695","article-title":"STING agonists as cancer therapeutics","volume":"13","author":"Amouzegar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.biomaterials.2026.124238_bib24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/imr.12765","article-title":"STING pathway agonism as a cancer therapeutic","volume":"290","author":"Flood","year":"2019","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.biomaterials.2026.124238_bib25","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1038\/s41586-018-0705-y","article-title":"Design of amidobenzimidazole STING receptor agonists with systemic activity","volume":"564","author":"Ramanjulu","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124238_bib26","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2967\/jnumed.122.264121","article-title":"18F-FDG PET visualizes systemic STING agonist-induced lymphocyte activation in preclinical models","volume":"64","author":"Le","year":"2023","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.biomaterials.2026.124238_bib28","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1021\/acscentsci.4c00579","article-title":"STING-activating polymer\u2013drug conjugates for cancer immunotherapy","volume":"10","author":"Sheehy","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biomaterials.2026.124238_bib29","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acscentsci.3c01310","article-title":"Mannosylated STING agonist drugamers for dendritic cell-mediated cancer immunotherapy","volume":"10","author":"Nguyen","year":"2024","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.biomaterials.2026.124238_bib30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jconrel.2024.07.004","article-title":"Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment","volume":"373","author":"Lee","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124238_bib31","doi-asserted-by":"crossref","first-page":"28973","DOI":"10.1021\/jacs.4c09831","article-title":"A type I photosensitizer-polymersome boosts reactive oxygen species generation by forcing H-Aggregation for amplifying STING immunotherapy","volume":"146","author":"Wang","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124238_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adtp.202100130","article-title":"Polymersome nanoreactor-mediated combination Chemodynamic-Immunotherapy via ROS production and enhanced STING activation","volume":"4","author":"Zhou","year":"2021","journal-title":"Adv. Therapeut."},{"key":"10.1016\/j.biomaterials.2026.124238_bib33","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1021\/acsnano.3c11464","article-title":"Dual-responsive nanomedicine activates programmed antitumor immunity through targeting lymphatic system","volume":"18","author":"Xiao","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2026.124238_bib34","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1038\/s41467-023-37328-9","article-title":"STING agonist-loaded, CD47\/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124238_bib35","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.3390\/molecules28093740","article-title":"Anticancer effect of STING agonist-encapsulated liposomes on breast cancer","volume":"28","author":"Zhang","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.biomaterials.2026.124238_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102365","article-title":"Co-delivery of STING and TLR7\/8 agonists in antigen-based nanocapsules to dendritic cells enhances CD8+ T cell-mediated melanoma remission","volume":"57","author":"Schunke","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124238_bib37","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","article-title":"Polymer\u2013drug conjugate therapeutics: advances, insights and prospects","volume":"18","author":"Ekladious","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.biomaterials.2026.124238_bib38","doi-asserted-by":"crossref","first-page":"270","DOI":"10.15283\/ijsc24060","article-title":"Glutathione dynamics in the tumor microenvironment: a potential target of cancer stem cells and T cells","volume":"17","author":"Park","year":"2024","journal-title":"Int. J. Stem Cells"},{"key":"10.1016\/j.biomaterials.2026.124238_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/btm2.10677","article-title":"Antibody drug conjugates in the clinic","volume":"9","author":"Udofa","year":"2024","journal-title":"Bioeng. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124238_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122812","article-title":"Shear-thinning hydrogel for allograft cell transplantation and externally controlled transgene expression","volume":"314","author":"Bezold","year":"2025","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2026.124238_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/polym12020298","article-title":"The importance of poly(ethylene glycol) alternatives for overcoming PEG immunogenicity in drug delivery and bioconjugation","volume":"12","author":"Hoang Thi","year":"2020","journal-title":"Polymers"},{"key":"10.1016\/j.biomaterials.2026.124238_bib42","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.apsb.2024.02.006","article-title":"Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biomaterials.2026.124238_bib43","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/ci500467k","article-title":"iLOGP: a simple, robust, and efficient description of n-Octanol\/Water partition coefficient for drug design using the GB\/SA approach","volume":"54","author":"Daina","year":"2014","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.biomaterials.2026.124238_bib44","doi-asserted-by":"crossref","first-page":"35149","DOI":"10.1021\/jacs.5c13195","article-title":"Macromolecular diamidobenzimidazole conjugates can activate stimulator of interferon genes","volume":"147","author":"Arora","year":"2025","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2026.124238_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103094","article-title":"Low-molecular-weight thiol transferases in redox regulation and antioxidant defence","volume":"71","author":"Tossounian","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib46","unstructured":"The Role of Glutathione in Cancer - Balendiran - 2004 - Cell Biochemistry and Function - Wiley Online Library, (n.d.). https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/cbf.1149 (accessed February 12, 2026)."},{"key":"10.1016\/j.biomaterials.2026.124238_bib47","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41586-025-08758-w","article-title":"STING agonist-based ER-targeting molecules boost antigen cross-presentation","volume":"641","author":"Wang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124238_bib48","article-title":"Formation and reshuffling of disulfide bonds in bovine serum albumin demonstrated using tandem mass spectrometry with collision-induced and electron-transfer dissociation","volume":"5","author":"Rombouts","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biomaterials.2026.124238_bib49","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1039\/C6SC01831A","article-title":"Decoupling stability and release in disulfide bonds with antibody-small molecule conjugates \u2020electronic supplementary information (ESI)","volume":"8","author":"Pillow","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.biomaterials.2026.124238_bib50","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1158\/0008-5472.CAN-20-3182","article-title":"Multimodal molecular imaging detects early responses to immune checkpoint blockade","volume":"81","author":"Saida","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124238_bib51","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1421891","article-title":"Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors","volume":"7","author":"Crosby","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.biomaterials.2026.124238_bib52","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41563-022-01251-z","article-title":"STING agonist delivery by tumour-penetrating PEG-lipid nanodiscs primes robust anticancer immunity","volume":"21","author":"Dane","year":"2022","journal-title":"Nat. Mater."},{"key":"10.1016\/j.biomaterials.2026.124238_bib53","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/s41565-021-00962-9","article-title":"Amplifying STING activation by cyclic dinucleotide\u2013manganese particles for local and systemic cancer metalloimmunotherapy","volume":"16","author":"Sun","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib54","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.semdp.2020.06.003","article-title":"Spleen: development, anatomy and reactive lymphoid proliferations","volume":"38","author":"Crane","year":"2021","journal-title":"Semin. Diagn. Pathol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib55","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13045-025-01691-5","article-title":"The cGAS\u2012STING pathway in cancer immunity: mechanisms, challenges, and therapeutic implications","volume":"18","author":"Shen","year":"2025","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib56","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1158\/1078-0432.CCR-18-1449","article-title":"The first-week proliferative response of peripheral blood PD-1+CD8+ T cells predicts the response to Anti-PD-1 therapy in solid tumors","volume":"25","author":"Kim","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2026.124238_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2026.124238_bib58","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.addr.2007.11.009","article-title":"Polymer-drug conjugates: recent development in clinical oncology","volume":"60","author":"Li","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biomaterials.2026.124238_bib59","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1016\/j.drudis.2013.09.007","article-title":"Polymer\u2013drug conjugates: present state of play and future perspectives","volume":"18","author":"Pang","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biomaterials.2026.124238_bib60","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/ars.2010.3684","article-title":"Disulfide reduction in the endocytic pathway: immunological functions of gamma-interferon-inducible lysosomal thiol reductase","volume":"15","author":"Hastings","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.biomaterials.2026.124238_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00604","article-title":"Targeted APC activation in cancer immunotherapy to enhance the abscopal effect","volume":"10","author":"Suek","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001906","article-title":"STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment","volume":"9","author":"Chelvanambi","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.biomaterials.2026.124238_bib63","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.progpolymsci.2007.05.008","article-title":"Polymer\u2013drug conjugation, recent achievements and general strategies","volume":"32","author":"Pasut","year":"2007","journal-title":"Prog. Polym. Sci."},{"key":"10.1016\/j.biomaterials.2026.124238_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121863","article-title":"Polymer-drug conjugates: design principles, emerging synthetic strategies and clinical overview","volume":"623","author":"Javia","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biomaterials.2026.124238_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110302","article-title":"Grand challenges in nanomedicine","volume":"106","author":"Wu","year":"2020","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.biomaterials.2026.124238_bib66","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.3390\/pharmaceutics15092216","article-title":"Innovative design of targeted nanoparticles: Polymer\u2013drug conjugates for enhanced cancer therapy","volume":"15","author":"Junyaprasert","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biomaterials.2026.124238_bib67","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12951-025-03209-0","article-title":"Emerging strategies against accelerated blood clearance phenomenon of nanocarrier drug delivery systems","volume":"23","author":"Pan","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.biomaterials.2026.124238_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102163","article-title":"Anti-PEG antibodies: current situation and countermeasures","volume":"55","author":"Fu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2026.124238_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fchbi.2024.1386220","article-title":"Putting the sting back in STING therapy: novel delivery vehicles for improved STING activation","volume":"3","author":"Khorsandi","year":"2024","journal-title":"Front. Chem. Biol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib70","article-title":"Overcoming challenges in the delivery of STING agonists for cancer immunotherapy: a comprehensive review of strategies and future perspectives","volume":"23","author":"Huang","year":"2023","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.biomaterials.2026.124238_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abi9002","article-title":"A diamidobenzimidazole STING agonist protects against SARS-CoV-2 infection","author":"Humphries","year":"2021","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.biomaterials.2026.124238_bib72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa4306","article-title":"STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade","author":"Fu","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2026.124238_bib73","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2017.11.030","article-title":"A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination","volume":"270","author":"Junkins","year":"2018","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2026.124238_bib74","doi-asserted-by":"crossref","first-page":"6053","DOI":"10.1038\/s41467-024-50234-y","article-title":"An intranasal nanoparticle STING agonist protects against respiratory viruses in animal models","volume":"15","author":"Leekha","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2026.124238_bib75","doi-asserted-by":"crossref","first-page":"8458","DOI":"10.1016\/j.polymer.2004.12.061","article-title":"Advances in RAFT polymerization: the synthesis of polymers with defined end-groups","volume":"46","author":"Moad","year":"2005","journal-title":"Polymer"},{"key":"10.1016\/j.biomaterials.2026.124238_bib76","doi-asserted-by":"crossref","first-page":"5091","DOI":"10.1002\/pola.26941","article-title":"Synthesis of click-reactive HPMA copolymers using RAFT polymerization for drug delivery applications","volume":"51","author":"Ebbesen","year":"2013","journal-title":"J. Polym. Sci. Polym. Chem."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961226002620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T17:27:55Z","timestamp":1794763675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961226002620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":75,"alternative-id":["S0142961226002620"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124238","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A molecularly defined polymeric platform for environmentally responsive activation of STING to enhance cancer immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2026.124238","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"124238"}}